April 24th, 2013
Quinidine In Ireland: Rarely Needed, Hard To Find
Gerard J Fahy, MD, Niamh O'Hanlon, BPharm MSc Grad Dip Risk Mgmt Cert Pharm Prac and John Ryan, MD
Recently in the Journal of the American College of Cardiology Viskin et al published the results of a survey looking at the worldwide availability of quinidine. They found that the drug — the only effective oral antiarrhythmic in Brugada syndrome and idiopathic ventricular fibrillation — is readily available in only 19 countries and is unavailable or […]
April 9th, 2013
Quinidine Unavailable in Most of the World
Larry Husten, PHD
Quinidine — the only drug known to be effective in preventing lethal ventricular arrhythmias in people with several rare conditions, including Brugada syndrome, idiopathic ventricular fibrillation (VF), and early repolarization syndrome — is no longer available in much of the world. In a study published online in the Journal of the American College of Cardiology, Sami Viskin and colleagues surveyed […]
NEJM Journal Watch — Recent Cardiology Articles- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?
- Does Lowering High Childhood Lipid Levels Prevent Adverse Cardiovascular Events in Adulthood?
- Self-Expanding Supraannular Valve vs. Balloon-Expandable Valve in TAVR for Small Aortic Annulus
- A New TAVR Prosthesis for Aortic Regurgitation Shows Promise
- Aprocitentan, a Newly Approved Drug for Resistant Hypertension